跳至主要内容
临床试验/KCT0009435
KCT0009435招募中Unknown

Comparison of the effect of intravenous ondansetron administration on vasopressor requirements and the corrected QT for preventing spinal hypotension during cesarean delivery under spinal anesthesia: A Prospective, Randomized, double-blinded study

Asan Medical Center0 个研究点目标入组 110 人开始时间: 待定最近更新:
适应症

试验速览

阶段
Unknown
状态
招募中
入组人数
110

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
20(Year) 至 45(Year)(—)
性别
Female

入选标准

  • 1) Singleton, Gestational age 37 weeks or more
  • 2) Scheduled for spinal anesthesia
  • 3) from 20 years to 45 years
  • 4) No contraindications of spinal anesthesia
  • 5) Body mass index 35 kg/m2 or less
  • 6) American society of anesthesiologists physical status 2

排除标准

  • 1) Past history of side effects related to the use of ondansetron, history of inadequate response to the antiemetic effect of ondansetron
  • 2) Failure of spinal anesthesia (conversion to general anesthesia, unexpected analgesia or sedatives administration due to inadequate spinal anesthesia)
  • 3) Emergency cesarean section (category 1) such as placental abruption, umbilical cord prolapse
  • 4) Cases where blood transfusion is expected (etc. placenta accreta spectrum)
  • 5) Accompanying pregnancy related complications such as hypertension, pre-eclampsia, eclampsia , etc
  • 6) Magnesium treatment during the pre/postoperative period
  • 7) Electrolyte imbalance including hypokalemia, hypomagnesemia and others, Drug administration causing electrolyte imbalance
  • 8) Congestive heart failure, possibility or presence of Long QT syndrome, and brady-arrhythmia
  • 9) Administration of Selective-serotonin reuptake inhibitor and serotonin-norepinephrine reuptake inhibitor
  • 10) Drug administration related to QT prolongation: Cardiotoxic drugs (e.g.anthracycline), antibiotics (e.g.erythromycin), anti-fungal agents (e.g.ketoconazol), anti-arrhythmic agents (e.g.amiodarone), beta-blocker, etc
  • 11) If there is or is expected to be a neurological deficit
  • 12) Expected birth weight less than 1500 (Very low birth weight)
  • 13) Patient who have already administered a Selective 5-HT3 receptor antagonist, or patients having an allergy or hypersensitivity to selective 5-HT3 receptor antagonist
  • 14) Regarded as inappropriate to participate this study by Medical staff

研究者

相似试验